Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

被引：3
作者：
Menon, Lalitha L. [1 ]
Chin, Beatrice [1 ]
Khattak, Muhammad A. [1 ,2 ,3 ]
机构：
[1] Fiona Stanley Hosp, Dept Oncol, Perth, WA, Australia
[2] Univ Western Australia, Dept Med Oncol, Perth, WA, Australia
[3] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2018年 / 48卷 / 12期
关键词：
D O I：
10.1111/imj.14131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1542 / 1543
页数：2
相关论文
共 50 条
  • [31] ADHERENCE TO EXPECTED TREATMENT DURATION FOR PATIENTS WITH HEPATITIS C TREATED WITH LEDIPASVIR/SOFOSBUVIR
    Puenpatom, A.
    Hull, M.
    McPheeters, J.
    Schwebke, K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S744 - S745
  • [32] Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study
    Dar, Gulzar A.
    Yattoo, Ghulam N.
    Gulzar, Ghulam M.
    Sodhi, Jaswinder S.
    Gorka, Suresh
    Laway, Mushtaq A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (02) : 227 - 231
  • [33] Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Subjects Aged 65 Years or Older
    Saab, Sammy
    Park, Sarah H.
    Mizokami, Masashi
    Omata, Masao
    Mangia, Alessandra
    Eggleton, Ed
    Zhu, Yanni
    Knox, Steven J.
    Pang, Phil
    Subramanian, Mani
    Kowdley, Kris
    Afdhal, Nezam H.
    HEPATOLOGY, 2016, 63 (04) : 1112 - 1119
  • [34] Ledipasvir-Sofosbuvir-Combination in chronic Hepatitis C?
    Escher, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (25-26) : 13331 - 13331
  • [35] A pharmacokinetic and treatment study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus
    Chappell, C.
    Kirby, B.
    Scarsi, K.
    Suri, V.
    Gaggar, A.
    Krans, E.
    Macio, I.
    Meyn, L.
    Bogen, D.
    Bunge, K.
    Hillier, S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (06) : 666 - 666
  • [36] Association of Ledipasvir-Sofosbuvir Treatment With Uveitis in Patients Treated for Hepatitis C
    Padidam, Sneha
    Burke, Marie T.
    Apple, Daniel B.
    Hu, Jonathan K.
    Lin, Xihui
    JAMA OPHTHALMOLOGY, 2019, 137 (05) : 568 - 570
  • [37] Ledipasvir-sofosbuvir (Harvoni) response and treatment duration in a hepatitis C virus genotype 1 cohort: A claims data analysis from a health plan perspective
    Castel, Liana D.
    Henshaw, Gary
    Canes, Aran
    Stambaugh, Thom
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 302 - 302
  • [38] Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naive Children without and with Comorbidities
    AbouBakr, Othman
    El Regal, Mohammed Ezz
    Sarhan, Amr Ali
    Zaki, Maysaa El Sayed
    Noaman, Ahmed
    PEDIATRIC DRUGS, 2022, 24 (05) : 529 - 537
  • [39] Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c
    Ikeda, Atsuyuki
    Ikeda, Kaori
    Takai, Atsushi
    Takahashi, Ken
    Ueda, Yoshihide
    Marusawa, Hiroyuki
    Seno, Horoshi
    Inagaki, Nobuya
    Kokuryu, Hiroyuki
    DIGESTION, 2017, 96 (04) : 228 - 230
  • [40] Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
    Ahmed, Ossama A.
    Kaisar, Hany H.
    Badawi, Rehab
    Hawash, Nehad
    Samir, Hossam
    Shabana, Sherif S. T.
    Fouad, Mohamed Hassan A.
    Rizk, Fatma H.
    Khodeir, Samy A.
    Abd-Elsalam, Sherief
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 295 - 298
12345